Literature DB >> 12133982

Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection.

M Azizul Haque1, Teruaki Mizobuchi, Kazuhiro Yasufuku, Takehiko Fujisawa, Randy R Brutkiewicz, Yan Zheng, Kena Woods, Gerald N Smith, Oscar W Cummings, Kathleen M Heidler, Janice S Blum, David S Wilkes.   

Abstract

We have reported that lung allograft rejection involves an immune response to a native protein in the lung, type V collagen (col(V)), and that col(V)-induced oral tolerance prevented acute and chronic rejection. In support of these findings col(V) fragments were detected in allografts during rejection, but not in normal lungs. The purpose of the current study was to isolate and characterize col(V)-specific allograft-infiltrating T cells and to determine their contribution to the rejection response in vivo. Two col(V)-specific T cell lines, LT1 and LT3, were isolated from F344 (RT1(lv1)) rat lung allografts during rejection that occurred after transplantation into WKY (RT1(l)) recipients. Both cell lines, but not normal lung lymphocytes, proliferated in response to col(V). Neither LT1 nor LT3 proliferated in response to alloantigens. LT1 and LT3 were CD4(+)CD25(-) and produced IFN-gamma in response to col(V). Compared with normal CD4(+) T cells, both cell lines expressed a limited V-beta TCR repertoire. Each cell strongly expressed V-beta 9 and 16, but differed in expression of other V-betas. Adoptive transfer of each cell line did not induce pathology in lungs of normal WKY rats. In contrast, adoptive transfer of LT1, but not LT3, caused marked peribronchiolar and perivascular inflammation in isograft (WKY) lungs and abrogated col(V)-induced oral tolerance to allograft (F344) lungs. Collectively, these data show that lung allograft rejection involves both allo- and autoimmune responses, and graft destruction that occurs during the rejection response may expose allograft-infiltrating T cells to potentially antigenic epitopes in col(V).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12133982     DOI: 10.4049/jimmunol.169.3.1542

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  65 in total

1.  Autoimmune sensitization to cardiac myosin leads to acute rejection of cardiac allografts in miniature swine.

Authors:  Gregory R Veillette; Hisashi Sahara; Andrew J Meltzer; Mathew J Weiss; Yoshiko Iwamoto; Karen M Kim; Bruce R Rosengard; James S Allan; Stuart L Houser; David H Sachs; Gilles Benichou; Joren C Madsen
Journal:  Transplantation       Date:  2011-06-15       Impact factor: 4.939

2.  Immune responses to self-antigens in asthma patients: clinical and immunopathological implications.

Authors:  Michael Liu; Vijay Subramanian; Chandrika Christie; Mario Castro; Thallachallour Mohanakumar
Journal:  Hum Immunol       Date:  2012-02-17       Impact factor: 2.850

3.  Genetic elimination of α3(IV) collagen fails to rescue anti-collagen B cells.

Authors:  Amy G Clark; Katherine M Mackin; Mary H Foster
Journal:  Immunol Lett       Date:  2011-09-24       Impact factor: 3.685

Review 4.  Regulatory T cells in lung transplantation--an emerging concept.

Authors:  David C Neujahr; Christian P Larsen
Journal:  Semin Immunopathol       Date:  2011-03-20       Impact factor: 9.623

Review 5.  Lung transplantation: opportunities for research and clinical advancement.

Authors:  David S Wilkes; Thomas M Egan; Herbert Y Reynolds
Journal:  Am J Respir Crit Care Med       Date:  2005-07-14       Impact factor: 21.405

Review 6.  Mechanisms of chronic rejection in cardiothoracic transplantation.

Authors:  Matthew J Weiss; Joren C Madsen; Bruce R Rosengard; James S Allan
Journal:  Front Biosci       Date:  2008-01-01

Review 7.  Allopeptides and the alloimmune response.

Authors:  Ankit Bharat; T Mohanakumar
Journal:  Cell Immunol       Date:  2007-07       Impact factor: 4.868

8.  Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients.

Authors:  Sarah A Imam; Mary K Guyton; Azizul Haque; Arthur Vandenbark; William R Tyor; Swapan K Ray; Naren L Banik
Journal:  J Neuroimmunol       Date:  2007-09-04       Impact factor: 3.478

9.  Pulsed low-dose RANKL as a potential therapeutic for postmenopausal osteoporosis.

Authors:  Anna Cline-Smith; Jesse Gibbs; Elena Shashkova; Zachary S Buchwald; Deborah V Novack; Rajeev Aurora
Journal:  JCI Insight       Date:  2016-08-18

10.  The presence of a matrix-derived neutrophil chemoattractant in bronchiolitis obliterans syndrome after lung transplantation.

Authors:  Matthew T Hardison; F Shawn Galin; Christopher E Calderon; Uros V Djekic; Suzanne B Parker; Keith M Wille; Patricia L Jackson; Robert A Oster; K Randall Young; J Edwin Blalock; Amit Gaggar
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.